UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer

British journal of cancer, 2012-03, Vol.106 (7), p.1249-1258

2012

Volltextzugriff (PDF)

399 Rho-GTPase, RAC1 and Cdc42 mediates Wnt–beta-catenin signals for metastasis associated phenotypes in TNBC: A proof of concept study

European journal of cancer (1990), 2014-11, Vol.50, p.128-128

2014

Volltextzugriff (PDF)

EGFR-targeting drugs in combination with cytotoxic agents: from bench to bedside, a contrasted reality

British journal of cancer, 2008-07, Vol.99 (1), p.1-5

2008

Volltextzugriff (PDF)

Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial

Annals of oncology, 2018-10, Vol.29, p.viii70-viii70

2018

Volltextzugriff (PDF)

Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts

British journal of cancer, 2010-02, Vol.102 (3), p.570-576

2010

Volltextzugriff (PDF)

2753 Feasibility of implementing routine genomic and proteomic profiling for advanced GYN malignancies

European journal of cancer (1990), 2015-09, Vol.51, p.S548-S548

2015

Volltextzugriff (PDF)

375 Dual PI3K/mTOR and HER2 Blockade Results in Antitumor Efficacy in Preclinical Models of HER2+ Breast Cancer Resistant to Trastuzumab Therapy

European journal of cancer (1990), 2012-11, Vol.48, p.114-115

2012

Volltextzugriff (PDF)

376 Wnt-beta-catenin Pathway Controls Metastasis-associated Phenotypes of Tumor Cells in the Triple Negative Subset of Breast Cancer: a Proof of Concept Study

European journal of cancer (1990), 2012-11, Vol.48, p.115-115

2012

Volltextzugriff (PDF)

Promises and caveats of in silico biomarker discovery

British journal of cancer, 2008-08, Vol.99 (3), p.385-386

2008

Volltextzugriff (PDF)

Pharmacokinetic and clinical equivalence of oral and intravenous ibandronate for metastatic bone disease

European journal of cancer supplements, 2004-04, Vol.2 (5), p.9-12

Leyland-Jones, B.

2004

Volltextzugriff (PDF)

Of mice and men: the evolution of animal welfare guidelines for cancer research

British journal of cancer, 2010-05, Vol.102 (11), p.1553-1554

2010

Volltextzugriff (PDF)

PP 26 IGF-1R signaling in ER+ and triple negative breast cancer - a potential target for therapy?

European journal of cancer (1990), 2011, Vol.47, p.S16-S16

2011

Volltextzugriff (PDF)

P068 Sequencing to identify potential targets of resistance to primary therapy

Breast (Edinburgh), 2015-03, Vol.24, p.S50-S50

2015

Volltextzugriff (PDF)

P049 Genomic landscape of the PI3K pathway and cell-cycle pathway in ER+ BC: a treatment strategy

Breast (Edinburgh), 2015-03, Vol.24, p.S43-S43

2015

Volltextzugriff (PDF)

PP 25 Preclinical efficacy of a dual PI3K-mTOR inhibitor, BEZ235 in triple negative breast cancer

European journal of cancer (1990), 2011, Vol.47, p.S17-S17

2011

Volltextzugriff (PDF)

Comparative analysis of xanafide cytotoxicity in breast cancer cell lines

British journal of cancer, 2007-07, Vol.97 (1), p.58-64

2007

Volltextzugriff (PDF)

S2 Recommendations for collection and handling of specimens from group breast cancer clinical trials, from onsite collection through shipping to the central bank

European journal of cancer supplements, 2007, Vol.5 (8), p.5-5

Leyland-Jones, B

2007

Volltextzugriff (PDF)

Comparative Cytotoxicity of C-1311 in Colon Cancer In Vitro and In Vivo Using the Hollow Fiber Assay

Journal of chemotherapy (Florence), 2007-10, Vol.19 (5), p.546-553

2007

Volltextzugriff (PDF)

The systemic administration of intravenous melphalan

Journal of clinical oncology, 1988-11, Vol.6 (11), p.1768-1782

1988

Volltextzugriff (PDF)

Synthesis and structure-activity relationships of 2-pyrazinylcarboxamidobenzoates and β-ionylideneacetamidobenzoates with retinoidal activity

Journal of medicinal chemistry, 1998-07, Vol.41 (16), p.3062-3077

1998

Volltextzugriff (PDF)

A phase II trial of mitomycin, ifosfamide and cisplatin in recurrent carcinoma of the cervix

International journal of gynecological cancer, 2000-05, Vol.10 (3), p.207-211

2000

Volltextzugriff (PDF)

S25 Update of the HERA trial and the role of 1 year Trastuzumab as adjuvant therapy for breast cancer

Breast (Edinburgh), 2009, Vol.18, p.S11-S11

2009

Volltextzugriff (PDF)

Treatment of cancer-related hypercalcemia: the role of gallium nitrate

Seminars in oncology, 2003-04, Vol.30 (2 Suppl 5), p.13-19, Article as0093775403001714

Leyland-Jones, Brian

2003

Volltextzugriff (PDF)

229 POSTER Combination effects of SF1126, a vascular targeted PI3 kinase inhibitor, with herceptin in Her-2 overexpressing breast cancer cells

European journal of cancer supplements, 2008, Vol.6 (12), p.72-72

2008

Volltextzugriff (PDF)

Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies

Journal of clinical oncology, 1991-01, Vol.9 (1), p.175-188

1991

Volltextzugriff (PDF)

1 – 25 von 235

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(208)
Mit Volltextzugriff
(202)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(79)
Life Sciences & Biomedicine
(76)
Science & Technology
(76)
Oncology
(61)
Biological And Medical Sciences
(48)
Medical Sciences
(47)
Pharmacology. Drug Treatments
(40)
Animals
(33)
Drug Evaluation
(31)
Antineoplastic Agents
(27)
Neoplasms - Drug Therapy
(23)
Antineoplastic Agents - Therapeutic Use
(18)
Pharmacology & Pharmacy
(18)
Clinical Trials As Topic
(17)
General Aspects
(17)
Mice
(16)
Chemotherapy
(15)
Drug Evaluation, Preclinical
(14)
Kinetics
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer

399 Rho-GTPase, RAC1 and Cdc42 mediates Wnt–beta-catenin signals for metastasis associated phenotypes in TNBC: A proof of concept study

EGFR-targeting drugs in combination with cytotoxic agents: from bench to bedside, a contrasted reality

Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial

Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts

2753 Feasibility of implementing routine genomic and proteomic profiling for advanced GYN malignancies

375 Dual PI3K/mTOR and HER2 Blockade Results in Antitumor Efficacy in Preclinical Models of HER2+ Breast Cancer Resistant to Trastuzumab Therapy

376 Wnt-beta-catenin Pathway Controls Metastasis-associated Phenotypes of Tumor Cells in the Triple Negative Subset of Breast Cancer: a Proof of Concept Study

Promises and caveats of in silico biomarker discovery

Pharmacokinetic and clinical equivalence of oral and intravenous ibandronate for metastatic bone disease

Of mice and men: the evolution of animal welfare guidelines for cancer research

PP 26 IGF-1R signaling in ER+ and triple negative breast cancer - a potential target for therapy?

P068 Sequencing to identify potential targets of resistance to primary therapy

P049 Genomic landscape of the PI3K pathway and cell-cycle pathway in ER+ BC: a treatment strategy

PP 25 Preclinical efficacy of a dual PI3K-mTOR inhibitor, BEZ235 in triple negative breast cancer

Comparative analysis of xanafide cytotoxicity in breast cancer cell lines

S2 Recommendations for collection and handling of specimens from group breast cancer clinical trials, from onsite collection through shipping to the central bank

Comparative Cytotoxicity of C-1311 in Colon Cancer In Vitro and In Vivo Using the Hollow Fiber Assay

The systemic administration of intravenous melphalan

Synthesis and structure-activity relationships of 2-pyrazinylcarboxamidobenzoates and β-ionylideneacetamidobenzoates with retinoidal activity

A phase II trial of mitomycin, ifosfamide and cisplatin in recurrent carcinoma of the cervix

S25 Update of the HERA trial and the role of 1 year Trastuzumab as adjuvant therapy for breast cancer

Treatment of cancer-related hypercalcemia: the role of gallium nitrate

229 POSTER Combination effects of SF1126, a vascular targeted PI3 kinase inhibitor, with herceptin in Her-2 overexpressing breast cancer cells

Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies

Aktive Filter

Suchergebnisse filtern